Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03405285 · ClinicalTrials.gov registry record · NA
Connected Catheter Clinical Feasibility Study( CFS)
A NA study of Urinary Bladder, Neurogenic, sponsored by Spinal Singularity.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 2
- Study locations
NCT03405285: Completed NA study of Urinary Bladder, Neurogenic, sponsored by Spinal Singularity.
NCT03405285 is a NA study of Urinary Bladder, Neurogenic that has completed, run by Spinal Singularity. The registered enrollment target is 5 participants, below the 71-participant average among 7 other Urinary Bladder, Neurogenic trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03405285, a NA study of Urinary Bladder, Neurogenic, has completed, sponsored by Spinal Singularity.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objective of this study is to evaluate the safety and essential performance of the Connected Catheter System in males with neurogenic lower urinary tract dysfunction (NLUTD), both in an acute clinical setting, and during and extended period (up to 29 days) of home use.
Primary Outcome
Improved bladder management without injury or trauma to genito-urinary tract
Conditions Studied
Interventions
- DEVICE Connected Catheter
Study Locations (2)
California
- West Coast Urology, 11411 Brookshire Avenue, Suite 508 - Downey
- Tri Valley Urology, 25495 Medical Center Dr., Suite 204 - Murrieta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-02-28 |
| Est. Completion | 2018-06-30 |
| Phase | NA |
What the finished NCT03405285 record still lists
NCT03405285 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 71-participant average among 7 other Urinary Bladder, Neurogenic trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Urinary Bladder, Neurogenic appearing as the primary indexed condition, and to 1 intervention - of which Connected Catheter is the first listed.
NCT03405285 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03405285 about?
NCT03405285 is a clinical study titled "Connected Catheter Clinical Feasibility Study( CFS)". The objective of this study is to evaluate the safety and essential performance of the Connected Catheter System in males with neurogenic lower urinary tract dysfunction (NLUTD), both in an acute clinical setting, and during and extended period (up to 29 days) of home use.
What is the current status of trial NCT03405285?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2018-02-28. Estimated completion is 2018-06-30.
What conditions does trial NCT03405285 study?
This clinical trial studies the following conditions: Urinary Bladder, Neurogenic.
What interventions are being tested in trial NCT03405285?
The interventions under investigation include: Connected Catheter (DEVICE).
Who is sponsoring clinical trial NCT03405285?
This trial is sponsored by Spinal Singularity, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03405285 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Bladder, Neurogenic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Measurement of Bladder Pressure With a Novel External Device (Cystomanometer) - Home Use
RECRUITING · NA
-
Recovery of Bladder and Sexual Function After Human Spinal Cord Injury
RECRUITING · NA
-
Cystoealstometer (Bladder Monitor Device)-Home Use
ACTIVE NOT RECRUITING · NA
-
Evaluation of a Bowel and Bladder Health Management Program for Individuals With Spinal Cord Injury (SCI)
COMPLETED · NA
-
NXT Post-Market Clinical Follow-up
RECRUITING
-
Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI